ArticleMedical oncology (Northwood, London, England)2018

Long-term survival with modern therapeutic agents against metastatic melanoma-vemurafenib and ipilimumab in a daily life setting.

B M Lang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.